rethinkPeptides Search
Menu
RethinkPeptides

Autoimmune Diabetes and GLP-1

Explore peptide research and guides on autoimmune diabetes and glp-1.

Autoimmune Diabetes and GLP-1

Autoimmune Diabetes and GLP-1: The Research

GLP-1 receptor agonists are being studied as adjuncts to insulin in type 1 diabetes for weight loss, insulin reduction, and beta-cell support. Evidence review.

Autoimmune Diabetes and GLP-1

GLP-1 Drugs and Type 1 Diabetes Insulin Needs

Clinical trials show GLP-1 drugs like liraglutide, semaglutide, and tirzepatide reduce insulin requirements in type 1 diabetes by 8-35%. Here's what the evidence says.